News

Over at the Taiyuan Satellite Launch Center in the Shanxi Province, a CZ-6A launched Yaogan 40 Group 02 into polar orbit on ...
On the heels of a busy April, activity is ramping up for May with launches from five countries and six launch sites on three ...
Scientists do not fully understand why response to GLP-1s varies so widely among people prescribed them. Some benefits of GLP-1s occur independently of weight loss, so multiple factors are likely ...
As Computex gets underway in Taiwan Asus has unveiled a new graphics dock that could make all of those OCuLink-equipped models we’ve seen recently look like old news. Meanwhile mini PC maker GMK ...
Investing.com - Diabetes technology stocks have seen investor worries all but "vanish" over the possible negative implications of the emergence of popular obesity drugs, although it remains to be ...
“We’re both No. 1s,” Lamb told DLLS Cowboys. “It ain’t no [1A, 1B situation], none of that. It’s No. 1. You look over there, you see No. 1. You look over here, you see another No.
In a short but wide-ranging conversation, Hilberdink, who was only about a month into his job at the time, talked about the opportunity in GLP-1s, transparency in drug pricing, and the Trump ...
It follows a combative ad by telehealth company Hims & Hers, a major supplier of compounded GLP-1s in the US, that was broadcast during this year's Super Bowl and accused the pharma industry of ...
Many people struggle for years to lose weight and keep it off. Bariatric surgery and medications called GLP-1s (glucagon-like peptide-1 receptor agonists) are popular options for treating obesity.
But unlike previous cycles, where the spotlight stayed on majors, the current rotation is pulling capital into high-performance Layer 1s that haven’t yet exploded. According to multiple crypto ...
LeEco is making a huge push into content services in India, and the Le 1s Eco comes with a year-long subscription to the company's suite of apps for video and music. It remains to be seen if customers ...